The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy
Renin-angiotensin-aldosterone system inhibitors prevent the progression of kidney disease in patients with diabetic nephropathy, and we studied how that benefit varies by the type of diabetes and baseline urinary albumin. We pooled data from 49 randomized controlled trials in a meta-analysis using t...
Main Authors: | Taylor, K, Stevens, R, Blacklock, C, Roberts, N, Pugh, C, Farmer, A, Hirst, J |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2012
|
פריטים דומים
-
The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
מאת: Hirst, J, et al.
יצא לאור: (2012) -
Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.
מאת: Blacklock, C, et al.
יצא לאור: (2011) -
Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
מאת: Audrey Koitka, et al.
יצא לאור: (2008-01-01) -
Renin Angiotensin Aldosterone System Gene Polymorphisms among Type 2 Diabetic Patients with Retinopathy and Nephropathy
מאת: Vaishali S. Pawar, et al.
יצא לאור: (2024-12-01) -
View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
מאת: K. V. Skobeleva, et al.
יצא לאור: (2021-06-01)